Unit of Urology, Division of Experimental Oncology, URI Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina, 60, 20132, Milan, Italy.
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada.
World J Urol. 2021 Jul;39(7):2553-2558. doi: 10.1007/s00345-020-03504-5. Epub 2020 Oct 29.
The current literature regarding the effect of blood loss (eBL) after nephron-sparing surgery (NSS) on long-term renal function is scarce. We tested the effect of eBL on the risk of developing chronic kidney disease (CKD) after NSS.
Within an institutional prospectively maintained database, we identified 215 patients treated with NSS for cTNM renal mass at one European high-volume center. Multivariable logistic regression models tested the effect of eBL on the risk of developing CKD, after accounting for surgical complexity, individual clinical characteristics, and surgical experience. Multivariable linear regression models identified predictors of eBL.
After a median follow-up of 36 months, 55 (25.6%) patients experienced CKD after surgery. At multivariable analyses, eBL independently predicted higher risk of CKD after NSS (odds ratio [OR]: 1.16; 95% confidence intervals [CI] 1.04-1.30; p < 0.01). Specifically, the relationship between eBL and probability of CKD emerged as nonlinear, with a plateau from 0 to 500 mL of eBL and an increase afterward. When multivariable linear regression analyses investigated predictors of eBL, hypertension (Est: 127, 95% CI 12-242; p = 0.03), clinical size (Est: 47, 95% CI 7-87; p = 0.02), and PADUA score (Est: 42; 95% CI 4-80 p = 0.03) achieved independent predictor status for higher intraoperative eBL. Conversely, surgical experience was associated with lower eBL (p = 0.01).
Intraoperative bleeding is independently associated with the risk of developing CKD after surgery, even after adjustment for well-known predictors of renal failure and tumor complexity. Hence, strategies aimed at maximally reducing such adverse events deserve special consideration.
目前关于保肾手术后(NSS)失血(eBL)对长期肾功能影响的文献很少。我们测试了 eBL 对 NSS 后发生慢性肾脏病(CKD)风险的影响。
在一个机构前瞻性维护的数据库中,我们确定了一家欧洲高容量中心 215 例接受 NSS 治疗 cTNM 肾肿块的患者。多变量逻辑回归模型测试了 eBL 在考虑手术复杂性、个体临床特征和手术经验后对发生 CKD 的风险的影响。多变量线性回归模型确定了 eBL 的预测因素。
中位随访 36 个月后,55 例(25.6%)患者术后发生 CKD。多变量分析显示,eBL 可独立预测 NSS 后 CKD 的风险增加(比值比 [OR]:1.16;95%置信区间 [CI] 1.04-1.30;p<0.01)。具体来说,eBL 与 CKD 发生概率之间的关系是非线性的,eBL 从 0 到 500 毫升呈平台期,之后增加。当多变量线性回归分析调查 eBL 的预测因素时,高血压(估计值:127,95%CI 12-242;p=0.03)、临床大小(估计值:47,95%CI 7-87;p=0.02)和 PADUA 评分(估计值:42;95%CI 4-80 p=0.03)成为术中 eBL 较高的独立预测因素。相反,手术经验与 eBL 较低相关(p=0.01)。
即使在调整肾功能衰竭和肿瘤复杂性的已知预测因素后,术中出血仍与术后发生 CKD 的风险独立相关。因此,旨在最大限度减少此类不良事件的策略应得到特别考虑。